Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Oct 4.
Published in final edited form as: Bull Math Biol. 2016 Oct 4;78(10):2057–2090. doi: 10.1007/s11538-016-0211-z

Impact of population recruitment on the HIV epidemics and the effectiveness of HIV prevention interventions

Yuqin Zhao 1,, Daniel T Wood 2,, Hristo V Kojouharov 3, Yang Kuang 4, Dobromir T Dimitrov 5
PMCID: PMC5074698  NIHMSID: NIHMS821158  PMID: 27704329

Abstract

Mechanistic mathematical models are increasingly used to evaluate the effectiveness of different interventions for HIV prevention and to inform public-health decisions. By focusing exclusively on the impact of the interventions, the importance of the demographic processes in these studies is often underestimated. In this paper, we use simple deterministic models to assess the effectiveness of pre-exposure prophylaxis (PrEP) in reducing the HIV transmission and to explore the influence of the recruitment mechanisms on the epidemic and effectiveness projections. We employ three commonly used formulas that correspond to constant, proportional and logistic recruitment and compare the dynamical properties of the resulting models. Our analysis exposes substantial differences in the transient and asymptotic behavior of the models which result in 47% variation in population size and more than 6 percentage points variation in HIV prevalence over 40 years between models using different recruitment mechanisms. We outline the strong influence of recruitment assumptions on the impact of HIV prevention interventions and conclude that detailed demographic data should be used to inform the integration of recruitment processes in the models before HIV prevention is considered.

Keywords: Mathematical modeling, HIV prevention, Pre-exposure prophylaxis, Population recruitment

1 Introduction

In the last decade the HIV research focus moved toward development of prevention strategies and interventions. The field celebrated effective treatment options which almost eliminated mother-to-child transmission (Becquet et al. 2009), proven reduction of male risk through circumcision (Gray et al. 2007; Bailey et al. 2007; Auvert et al. 2005), as well as the advances in the treatment as prevention for serodiscordent couples (Cohen et al. 2011). Recently, significant attention and hope is associated with the growing number of promising options for pre-exposure prophylaxis (PrEP) which when applied topically, in the form of gels, or taken as a daily pill (oral PrEP) substantially reduce the risk of HIV acquisition (Karim et al. 2010; Grant et al. 2010; Baeten et al. 2012; Thigpen et al. 2012; Choopanya et al. 2013).

Mathematical models have been extensively employed to provide insights into the effectiveness and cost-effectiveness of different prevention programs (Abbas et al. 2007; Cremin et al. 2013; Desai et al. 2008; Dimitrov et al. 2010, 2011, 2012; Grant et al. 2010; Zhao et al. 2013; Supervie et al. 2010; Nichols et al. 2013; Juusola et al. 2012). Although focused on the intervention characteristics, such as efficacy mechanisms, roll out schedule, projected adherence and coverage these analyses necessarily model the demographic processes in the population such as births, sexual maturation, mortality and migration. In a recent article we argued that modeling efforts related to demographics deserve more attention (Dimitrov et al. 2014).

In this paper we compare some common modeling assumptions related to population recruitment and investigate their influence on the epidemic dynamics and projected effectiveness of PrEP use. Almost all models of HIV prevention interventions that have appeared in the scientific literature use either constant recruitment, assuming that a fixed number of individuals are joining the population per unit time (Wilson et al. 2008; Supervie et al. 2010; Sorensen et al. 2012; Kato et al. 2013; Dimitrov et al. 2013b; Abbas et al. 2013) or proportional recruitment, in which the number of “newcomers” is proportional to the population size (Vickerman et al. 2006; Granich et al. 2009; Bacaer et al. 2010; Cox et al. 2011; Eaton and Hallett 2014). In this study, we additionally consider logistic recruitment assuming that the number of people who join the population increases with population size but saturates at specific level driven by resource limitations. We modify a model (Zhao et al. 2013), previously used to project the impact of daily regimens of oral PrEP, to study the population dynamics and compare the efficacy of PrEP interventions under different recruitment assumptions. We demonstrate the impact of the recruitment assumptions using simple extensions of the classical SI model some of which have been already analyzed (Korobeinikov 2006; Hwang and Kuang 2003; Berezovsky et al. 2005). However, the comparison we present here is instrumental in understanding the importance of population recruitment which remain valid even when more complex models are employed.

The paper is organized as follows. In the next two sections population models in absence and presence of PrEP intervention are formulated, their asymptotic behavior is analyzed and compared under different recruitment assumptions. In Section 4, the influence of the recruitment assumptions on the projected intervention impact is investigated through numerical simulations. The efficacy of the PrEP intervention is estimated by various metrics using HIV epidemics simulated in the absence of PrEP as a baseline. The paper concludes with a brief discussion.

2 Modeling HIV epidemics in absence of PrEP

We first study the impact of three different assumptions about the recruitment rate on the population dynamics in the absence of PrEP. We consider the following model:

dSdt=f(N)βSINμSdIdt=βSIN(μ+d)I. (1)

with S(0) = (1−P)N0 and I(0) = PN0, where P is the initial HIV prevalence in the initial population of size N0. Here, the total population N is divided into two major classes, susceptibles (S) and infected (I). Frequency-dependent transmission is assumed and the cumulative HIV acquisition risk per year β is calculated based on the HIV risk per act (βa) with a HIV-positive partner and the average number of sex acts per year (n):

β=1(1βa)n.

Individuals join the population, i.e., become sexually active, at a rate f(N). We explore the effects of the following three different recruitment types: fC(N) = Λ, fP(N) = rN, and fL(N)=rN(1NK) corresponding to constant, proportional to size and logistic entrance rate, respectively. The values of the parameters have been identified from the literature or by fitting the simulated HIV dynamics to available empirical data. All model parameters are described in Table 1.

Table 1. Model parameters.

Parameter Description Baseline Value Reference
N0 Initial population size 27,172,431 (Africa 2012)
P Initial HIV prevalence 16.6% (Africa 2012)
Λ Constant recruitment: Fixed number of individuals who become sexually active annually 106 (Africa 2012)
r Proportional and logistic recruitment: Annual rate of individuals who become sexually active as a proportion of the total population
ΛN0ΛN0(1N0K)
calculated to ensure comparability
K Population carrying capacity 9 × 107 assumed
βa HIV acquisition risk per act 0.27% (Boily et al. 2009)
n Average number of sexual acts per year 80 (Wawer et al. 2005; Kalichman et al. 2009)
β Annual HIV acquisition risk in partnership with infected individual 19.5% calculated from βa and n
μ Annual departure rate based on background mortality and average time to remain sexually active 2.5% (UNAIDS 2009)
d Annual rate of progression to AIDS 12.5% (Morgan et al. 2002; Porter and Zaba 2004)
k Proportion of the new recruits using PrEP 20% assumed
αs Efficacy of PrEP in reducing susceptibility per act 50% (Karim et al. 2010; Baeten et al. 2012)

We are primarily interested in the projections of HIV prevalence which is estimated and reported periodically in the scientific literature as statistical data. Therefore, we focus on the dynamics of the fractions of susceptible ( s=SN) and infected ( i=IN=1s) individuals projected by the model (1).

The following propositions describe the asymptotic behavior of the model (1) without PrEP under different recruitment mechanisms. They summarize results that have been presented in published studies (Korobeinikov 2006; Hwang and Kuang 2003; Berezovsky et al. 2005).

Proposition 1 All solutions of Model (1) with non-negative initial conditions and constant recruitment fC(N) = Λ are non-negative and bounded with total population size N(t)max{N0,Λμ}.

If the basic reproduction number R0=βμ+d<1, then the model has a unique disease-free equilibrium Edf=(1μΛ,0) which is globally stable (see Fig.1a, Region 1). When R0 > 1, the disease-free equilibrium (Ed f) is unstable and the model possesses a unique endemic equilibrium E=(1βdΛ,1(βd)(R01)Λ) which is globally stable (Region 2).

Fig. 1.

Fig. 1

Bifurcation diagrams of models employing different recruitment functions in the absence of PrEP : (a) constant; (b) proportional; (c) logistic. Parameter regions in the plane of recruitment rate (Λ or r) and transmission rate (β) correspond to: 1- disease-free equilibrium, 2- endemic equilibrium, 3- population extinction in absence of HIV and 4- population extinction under the pressure of HIV. (d) Absolute difference in equilibrium HIV prevalence projected by models with constant/logistic and proportional recruitment when all other parameters are fixed at values in Table 1.

Proposition 2 All solutions of Model (1) with non-negative initial conditions and proportional recruitment fP(N) = rN are non-negative.

The unique steady state, Eext = (0, 0), of the model corresponds to population extinction. A solution of (1) either approaches Eext or the population size grows unbounded under endemic or disease-free conditions, depending on parameter values as follows (see Fig. 1b):

  • – When r < μ, all solutions are bounded and the population compartments (S(t), I(t)) → (0,0). The extinction steady state (Eext) is stable and the population goes extinct even in the absence of HIV (Region 3);

  • – When r > μ and β < r + d, the extinction steady state (Eext) is unstable and the population size grows unbounded with population fractions (s(t), i(t)) → (1,0) which corresponds to a disease-free equilibrium prevalence (Region 1);

  • – When μ < r < μ + d and r+d<β<(μ+d)dμ+dr, the extinction steady state (Eext) is unstable and the population size grows unbounded with population fractions (s(t), i(t)(rβd,1rβd). Endemic equilibrium prevalence (Region 2);

  • – When μ < r < m + d and β>(μ+d)dμ+dr, all solutions are bounded, (S(t), I(t)) → (0,0) with population fractions (s(t), i(t)(rβd,1rβd). The extinction steady state (Eext) is stable where population extinction is caused by HIV (Region 4);

  • – When r > μ + d and β > r + d, the extinction steady state (Eext) is unstable and the population size grows unbounded with population fractions (s(t), i(t)(rβd,1rβd). Endemic equilibrium prevalence (Region 2);

Proposition 3 All solutions of Model (1) with non-negative initial conditions and logistic recruitment fL(N)=rN(1NK) are non-negative. The model has three possible steady states: population extinction Eext = (0, 0), disease-free Edf=(rμrK,0) and endemic E=rμd(11R0)rK(1R0,R01R0) which exchange stability as follows (see Fig.1c):

  • – When r < μ, the disease free (Ed f) and the endemic (E*) equilibria do not exist. The extinction steady state (Eext) is globally stable. The population goes extinct even in the absence of HIV (Region 3);

  • – When r > μ and β < μ + d, the endemic equilibrium (E*) does not exist. The disease-free steady state (Ed f) is globally stable, while the extinction steady state (Eext) is unstable (Region 1);

  • – When μ < r < μ + d and μ+d<β<(μ+d)dμ+dr all three equilibria exist. The endemic steady state (E*) is globally stable, while the extinction (Eext) and the disease-free (Ed f) equilibria are unstable (Region 2);

  • – When μ < r < μ + d and β>(μ+d)dμ+dr, the endemic equilibrium (E*) does not exist. The extinction steady state (Eext) is globally stable, while the disease-free (Ed f) equilibrium is unstable. The population goes extinct under the pressure of HIV (Region 4);

  • – When r > μ + d and β > μ + d all three equilibria exist. The endemic steady state (E*) is globally stable, while the extinction (Eext) and the disease-free (Ed f) equilibria are unstable (Region 2);

Table 2 summarizes and compares the long-term dynamics of the model (1) under various recruitment assumptions. It shows that different recruitment mechanisms support different epidemic outcomes. Population always survives under constant recruitment while extinction, both independent of HIV and under HIV pressure, is possible when the proportional or the logistic recruitment is assumed. Furthermore, the shape and size of the biologically relevant regions of disease free and endemic conditions are different for different mechanisms. Notice that even when all models stabilize at endemic equilibrium the HIV prevalence under the the logistic and the constant recruitment is greater compared to under the proportional recruitment (see Fig. 1d). Moreover, assuming the endemic equilibrium is stable, the asymptotic HIV prevalence is completely independent of the recruitment rate assumed under constant/logistic mechanism, which is not case for the model with proportional recruitment. It should be noted however, that under logistic recruitment, the existence conditinos of the endemic equilibrium are dependent on the recruitment rate. Finally, unbounded projections, implying unlimited population growth, are featured under the proportional recruitment only.

Table 2.

Asymptotic behavior of the epidemic model (1) in the absence of PrEP under different recruitment assumptions.

Recruitment type Parameter conditions Epidemic outcome HIV prevalence at equilibrium Trajectory
Constant β < μ + d disease free 0 bounded
β > μ + d endemic
1μ+dβ
bounded

Proportional r > μ, β < r + d disease free 0 unbounded
r+d<β<(μ+d)dμ+dr
endemic
1rβd
unbounded
β>(μ+d)dμ+dr
extinction under HIV pressure - bounded
r < μ extinction in absence of HIV - bounded

Logistic r > μ, β < μ + d disease free 0 bounded
μ+d<β<(μ+d)dμ+dr
endemic
1μ+dβ
bounded
β>(μ+d)dμ+dr
extinction under HIV pressure - bounded
r < μ extinction in absence of HIV - bounded

3 Modeling HIV epidemics in the presence of PrEP

Next, we investigate the influence of the different recruitment mechanisms on the asymptotic dynamics of models that include PrEP interventions by considering the following system of differential equations:

dSpdt=kf(N)(1αs)βSpINμSpdSdt=(1k)f(N)βSINμSdIdt=βSIN+(1αs)βSpIN(μ+d)I (2)

with initial conditions:

Sp(0)=k(1P)N0S(0)=(1k)(1P)N0I(0)=PN0,

where P is the initial HIV prevalence, N0 is the initial population size, and k is the coverage of PrEP among susceptible individuals. Here, the population is divided into three major classes, according to their HIV and PrEP status: susceptible individuals who do not use PrEP (S); susceptible PrEP users (Sp) and infected individuals (I). A constant proportion k of the new recruits are assumed to start using PrEP. The same proportion of the susceptible individuals start on PrEP initially. Since PrEP provides imperfect protection against HIV, some of the PrEP users become infected. The risk of drug-resistance emergence among infected PrEP users has been discussed in the HIV prevention community (Dimitrov et al. 2012, 2013a; Supervie et al. 2010, 2011) and wide-scale PrEP interventions will likely include periodic HIV screening of all prescribed users. Therefore, we assume that PrEP users stop using the product after acquiring HIV and all infected individuals accumulate in the compartment (I).

Again, we explore the effects of the three different recruitment formulas: fC(N) = Λ, fP(N) = rN, and fL(N)=rN(1NK) corresponding to constant, proportional to size and logistic entrance rate.

The basic reproduction number of model (2) is given by R0=(1k)R0(S)+kR0(Sp)(1k)βμ+d+k(1αs)βμ+d=(1αsk)βμ+d.

Proposition 4 All solutions of Model (2) with non-negative initial conditions and constant recruitment fC(N) = Λ are non-negative and bounded. If R0 < 1 then the model has unique disease-free equilibrium Edf=(kμΛ,1kμΛ,0) which is locally stable (See Fig. 2(a), Region 1). Further, if R0<μμ+d then Ed f is globally stable. If R0 > 1 then Ed f is unstable and the model possesses unique endemic equilibrium E* which is locally stable (Region 2) and satisfies:

Fig. 2.

Fig. 2

Bifurcation diagrams of models in presence of PrEP employing different recruitment functions: (a) constant; (b) proportional; (c) logistic. Parameter regions in the plane of recruitment rate (Λ or r) and transmission rate (β) correspond to: 1- disease-free equilibrium, 2- endemic equilibrium, 3- population extinction in absence of HIV and 4- population extinction under the pressure of HIV. (d) Absolute difference in equilibrium HIV prevalence projected by models with constant/logistic and proportional recruitment when all other parameters are fixed at values in Table 1.

E=(Λ(ΛdI)μkΛ+((1αs)βd)I,Λ(ΛdI)μ1kΛ+(βd)I,I),

where I* is a solution of

F(I)βdμβμIΛdIαsβkΛ(1αs)βI+ΛdI=0

in the interval (0, Λd). The HIV prevalence associated with E* is iconst=μIΛdI.

Proposition 5 All solutions of Model (2) with non-negative initial conditions and proportional recruitment fP(N) = rN are non-negative.

The unique steady state Eext = (0,0,0) of the model implies population extinction. A solution of (2) either approaches Eext or the population size grows unbounded under endemic or disease-free conditions, depending on different parameter values as follows (see Fig.2(b)):

  • – When r < μ, all solutions are bounded and (Sp(t), S(t), I(t)) → (0,0,0). the extinction steady state (Eext) is stable and the population goes extinct even in the absence of HIV (Region 3);

  • – When r > μ and β<r+d1αsk, the extinction steady state (Eext) is unstable and the population size grows unbounded with population fractions (p(t), i(t)) → (k, 0) corresponding to disease-free equilibrium prevalence (Region 1);

  • – When μ < r < μ + d and r+d1αsk<β<β¯, the extinction steady state (Eext) is unstable and the population size grows unbounded with population fractions (p(t),i(t))(plin,ilin). Endemic equilibrium prevalence (Region 2);

  • – When μ < r < μ + d and β > β̄, all solutions are bounded and (Sp(t), S(t), I(t)) → (0, 0, 0). The extinction steady state (Eext) is stable where population extinction is caused by HIV (Region 4);

  • – When r > μ + d and β>r+d1αsk, the extinction steady state (Eext) is unstable and the population size grows unbounded with population fractions (p(t),i(t))(plin,ilin). Endemic equilibrium prevalence (Region 2);

Here, β̄ is the solution of the equation (8) derived in A. 5. As before p=SpN and i=IN represent the fractions of susceptibles PrEP users and infected individuals projected by the model (2) and ( plin,ilin) is the corresponding endemic equilibrium of the fractional model (4)-(5) derived in A.5.

Proposition 6 All solutions of Model (2) with non-negative initial conditions and logistic recruitment fL(N)=rN(1NK) are non-negative and bounded. The model has three possible equilibria corresponding to population extinction Eext = (0,0,0), disease-free Edf=(krμrK,(1k)rμrK,0) and endemic E=(Sp,S,I)=(plogN,(1plogilog)N,ilogN), where ( plog, ilog, N*) is the the equilibrium of the fractional model (9) derived in A.6. These steady states exchange stability as follows (see Fig. 2(c)):

  • – When r < μ, the disease free (Ed f) and the endemic (E*) equilibria do not exist. The extinction steady state (Eext) is globally stable. The population goes extinct even in the absence of HIV (Region 3);

  • – When r > μ and β<μ+d1αsk, the endemic equilibrium (E*) does not exist. The disease-free steady state (Ed f) is locally stable, while the extinction steady state (Eext) is unstable (Region 1);

  • – When μ < r < μ + d and μ+d1αsk<β<β¯, the endemic steady state (E*) is stable, while the extinction (Eext) and disease-free (Ed f) equilibria are unstable (Region 2);

  • – When μ < r < μ + d and β > β̄, the endemic equilibrium (E*) does not exist. The extinction steady state (Eext) is stable, while the disease-free (Ed f) is unstable. The population extincts under the pressure of HIV (Region 4);

  • – When r > μ + d and β>μ+d1αsk, the endemic steady state (E*) is stable, while the extinction (Eext) and disease-free (Ed f) equilibria are unstable (Region 2);

Moreover, the HIV prevalence associated with Model (2) under logistic and constant recruitment is the same, i.e., ilog=iconst. The results on the stability of the endemic equilibrium (E*) are only verified numerically.

Similar to the case without PrEP, different recruitment mechanisms yield a difference in the boundedness of the solutions and support different sets of epidemic outcomes with unequal HIV prevalence separated by different parameter conditions. The addition of PrEP does not change the shape of the regions with alternative epidemic outcome but rather complicates their boundary conditions. Notice that if the endemic equilibria are stable for the models under logistic and constant recruitment, the asymptotic HIV prevalence projected by those two models is the same, while the HIV prevalence under the proportional recruitment is lower compared to models with constant/logistic recruitment (Fig. 2d). Our analysis shows that, assuming the endemic equilibrium is stable, the asymptotic HIV prevalence under constant and logistic mechanisms is independent of the recruitment rate (for proof see A.6), but not if the proportional mechanism is employed. However, the existence conditions of the endemic equilibrium under logistic recruitment is dependent on the recruitment rate.

4 Public-health impact of PrEP interventions

The asymptotic behavior of the models described in the previous section is informative for the ability of the PrEP intervention to alter the course of the HIV epidemic in the long term. However, in reality the efficacy of PrEP is evaluated over specific initial period (up to 50 years) often by different quantitative metrics. We have demonstrated in previous work that the choice of evaluation method may influence the conclusions of the modeling analyses (Zhao et al. 2013). Here, we quantify the impact of PrEP interventions using four indicators borrowed from published modeling studies (see Table 4) and compare the influence of the recruitment mechanisms on the impact projected with each indicator. The fractional indicator (FI) measures the intervention efficacy as the proportion of the expected infections in the scenario without PrEP prevented when PrEP is used. The prevalence (PI) and incidence (aII) indicators measure the reduction in the projected HIV prevalence and incidence due to PrEP use, respectively. The last indicator (I) estimates the reduction of the number of infected individuals at any given time and correlates with the economic burden of the HIV epidemic on the public health system at community and state level since the money allocated for HIV treatment is proportional to the absolute number of infected individuals.

Table 4.

Evaluating the efficacy of PrEP intervention over a period of T years.

Indicator Description Formula*
FI(T) Fraction of infections prevented over the period [0, T]
1[INew(T)]p[INew(T)]
PI(T) Reduction in HIV-prevalence at time t = T
1[I(T)Sp(T)+S(T)+I(T)]p[I(T)S(T)+I(T)]
aII(T) Reduction in the HIV incidence for the period [T − 1, T]
1[INew(T)INew(T1)Sp(T1)+S(T1)]p[INew(T)INew(T1)S(T1)]
I(T) Proportion reduction in the number of infected at time t = T
1[I(T)]p[I(T)]
*

[ ]denotes variables from the model without PrEP (1) while [ ]P variables from the model with PrEP (2).

To track the cumulative number of new infections over time, we add the following equation to model (1):

d(INew)dt=βSIN,

and similarly to model (2):

d(INew)dt=βSIN+(1αs)βSpIN.

Numerical solutions of the models are obtained under different recruitment mechanisms f(N) keeping all the remaining parameters the same. We assume that the annual influx of people in the population is 1,000,000 initially which is the approximate number of 15-year olds in 2001 in the Republic of South Africa. We calculate the corresponding parameter values to ensure comparable recruitment for each mechanism. As a result, Λ = 106 is used for the model with constant recruitment, r=106N0 for the model with proportional recruitment and r=106KN0(KN0) with K = 9 × 107 for the model with logistic recruitment, where N0 = 27,172,431 is the initial population size representative for the 15-49 year-old population in South Africa (see Table 5). The resulting population dynamics over 200 years under scenarios with and without PrEP are presented in Figure 3. Note that with identical initial recruitment and using the same values for all other parameters, the population dynamics substantially diverge over the simulated period. In the absence of PrEP, the population suffers the smallest decrease in size (33%) under the constant recruitment scenario because the disease-related mortality does not impact the influx of newly susceptible people (Figure 3 (a),(c),(e)). In comparison, the population loses 94% and almost 100% over 200 years under the logistic and proportional recruitment scenarios. In addition to the population size, the proportion of infected individuals is affected as well. Assuming an initial HIV prevalence of 16.6%, the models predict that the HIV prevalence will raise to 24% with constant, 29% with logistic and 49% with proportional recruitment (Figure 3 (g)). The results do not change qualitatively if 20% of the population use PrEP. Naturally, for all recruitment methods the projected number of susceptible individuals is larger compared to the scenario without PrEP. However, the model with constant recruitment also projects smaller number of infected individuals versus the scenario without PrEP while the other methods show substantial increase in infected individuals due to the fact that healthier population size is preserved when PrEP is used. The relative order of the projected population size by recruitment mechanism remains the same (Figure 3 (b),(d),(f)). However, the dynamics predicted with logistic recruitment (dashed black lines) tend to stay closer to those with constant recruitment (solid blue lines) which was not the case when PrEP is not used. PrEP leads to significant reduction in HIV prevalence under all recruitment scenarios. Although the model with proportional recruitment is still most pessimistic on a long term with respect to HIV prevalence (18%), the other two mechanisms result in comparable projections of 13%. Note, that the infected proportion under constant recruitment remains smaller for at least 150 years compared to logistic recruitment, but after that the projections reverse (Figure 3 (h)).

Fig. 3.

Fig. 3

Population dynamics over 200 years for models with different recruitment rates: constant (blue –), proportional (red Inline graphic), and logistic (black --). Initial recruitment and parameter values unrelated to recruitment are kept the same across the models (see Table 1).

The impact of the recruitment on the projected PrEP efficacy is investigated in Figure 4. The choice of recruitment mechanisms shows no substantial impact over the initial period of 20-30 years but results in up to 18% difference in predicted reduction in HIV prevalence and incidence in longer term (Figure 4 (a),(b)). The model using proportional recruitment is most optimistic predicting 64% reduction in HIV prevalence and 68% in HIV incidence, respectively, over 200 years. Conversely, the model with constant recruitment projects largest fraction of infection prevented (Figure 4 (c)). Interestingly, the same indicator projects negative overall PrEP impact of the models with proportional and logistic recruitment after 102 and 130 years. It is the result of the critical decline in population size under the scenario without PrEP which limits the number of HIV infections in the long term.

Fig. 4.

Fig. 4

PrEP effectiveness over 200 years projected by models with different recruitment rates: constant (blue –), proportional (red Inline graphic), and logistic (black --). Initial recruitment and parameter values unrelated to recruitment are kept the same across the models (see Table 1).

Finally, we simulated the HIV epidemics by fitting the models with different recruitment rates to 10-year demographic and epidemic data representative for the Republic of South Africa (Africa 2012). Parameters values (Table 6) were determined to minimize a least square error between projected population and data (the number of susceptible and infected individuals) in the absence of PrEP following the approach proposed in a previous study (Zhao et al. 2013). The relative short duration of the fitted period did not allow for significant difference in the “best fit” parameters across models. As a result, the predictions of HIV dynamics and PrEP effectiveness with that “best fit” parameter sets (see Figure 5 and Figure 6 in the Appendix), were qualitatively similar to the simulations with fixed parameter sets (Fig. 3 and 4).

5 Discussion

Mathematical models are frequently used to estimate the expected efficacy of different interventions for HIV prevention under various epidemic settings. In this study, we demonstrated that the modeling assumptions regarding population recruitment can have a strong influence on the projected course of the HIV epidemic and as a result can impact the projected success of any planned interventions. We considered models equipped with three distinct recruitment mechanisms (constant, proportional, and logistic) and studied their behavior. Our analysis showed that the three models possess qualitatively different dynamic characteristics. The susceptible and infected populations stabilize in size to their respective equilibria under any feasible combination of parameters when constant recruitment is assumed. This model supports only two long-term outcomes corresponding to a disease-free and an endemic equilibrium, respectively. In comparison, the proportional and the logistic recruitment support four long-term outcomes including a disease free equilibrium, an endemic equilibrium, an equilibrium corresponding to population extinction under the pressure of HIV and an equilibrium corresponding to population extinction in absence of HIV. The parameter conditions where the transitions between asymptotic states occur (i.e., the bifurcation points) are the same for these two models but different from those for the model with the constant recruitment. On the other hand, the constant and the logistic model share an endemic fractional equilibrium which is different from the proportional model, i.e., they project different HIV prevalence in the long term. Somewhat unexpected, the recruitment rate has no influence on the asymptotic HIV prevalence when endemic equilibrium is reached under the constant and the logistic mechanisms while being of importance if the proportional mechanism is employed.

As a result, the simulations of HIV epidemics with the three models over 200 years show large discrepancies in the population size and HIV prevalence under identical initial conditions and forces of infection. The projected HIV prevalence varies from 24%, under constant recruitment, to 49%, under proportional recruitment. In addition, a significant difference in the reduction in HIV prevalence and incidence (almost 20%) is predicted when 50% effective PrEP is used by 20% of the population. Over the entire simulated period, the proportional recruitment provides the most optimistic estimates of the PrEP effectiveness in terms of a prevalence reduction while the constant recruitment predicts a larger fraction of infections prevented.

The models that we used to illustrate the importance of the recruitment mechanisms were purposely simple as to allow us for a more comprehensive analytical work. However, we believe that the same or even stronger impact of the choice of a recruitment treatment exists for compartmental models with higher level of complexity because the integration of the demographic processes such as births, sexual maturation and immigration remains the same. As a result, the differences in population size and distribution, which arise from the decision regarding recruitment, propagate into the epidemic dynamics and affect the intervention effectiveness.

It can be argued that, regardless of the differences in the dynamic behavior, all three models agree in their efficacy projections over 20-30 years, which is the usual period over which the interventions are evaluated. However, often the models are run for extended periods (till endemic equilibrium is reached) in order to simulate “mature” epidemics and the intervention is introduced afterward (Boily et al. 2004; Abbas et al. 2007). The key message of this analysis is that the way the recruitment is incorporated in the models impacts the HIV epidemic and may have a significant effect on the projected efficacy of different HIV interventions. Demographic data, including statistics on births and age-specific mortality, should be used to inform the modeling mechanisms before HIV prevention is considered. Our future research plans include exploring the importance of population recruitment and departure within both, compartmental and individual-based, modeling frameworks.

Table 3.

Asymptotic behavior of the epidemic models the in presence of PrEP (2) under different recruitment assumptions.

Recruitment type Parameter conditions Epidemic outcome HIV prevalence at equilibrium Trajectory
Constant
β<μ+d1αsk
disease free 0 bounded
β>μ+d1αsk
endemic
iconst
bounded

Proportional r > μ, β<r+d1αsk disease free 0 unbounded
r+d1αsk<β<β¯
endemic
ilin
unbounded
β > β̄ extinction under HIV pressure - bounded
r < μ extinction in absence of HIV - bounded

Logistic r > μ, β<μ+d1αs disease free 0 bounded
μ+d1αsk<β<β¯
endemic
ilog
bounded
β > β̄ extinction under HIV pressure - bounded
r < μ extinction in absence of HIV - bounded

Acknowledgments

This work is supported in part by NSF DMS-1518529. DTD is partially supported by NIH-UM1 AI068617.

Appendix

A Proofs of main results

A.1 Proof of Proposition 1

Positivity and boundedness of the solutions can be easily proved. Then periodic solutions can be excluded by Dulacs Criteria. Let P(S,I)dSdt and Q(S,I)dIdt, then SPSI+IQSI=ΛS2I<0.

Model (1) with constant recruitment fC(N) has two possible steady states Edf=(1μΛ,0) and E=(1βdΛ,1βd(R01)Λ), where R0=βμ+d. Notice that E* (positive steady state) exists if and only if R0 > 1.

The eigenvalues of the Jacobian evaluated at Ed f are λ1 = −μ < 0 and λ2 = (μ + d)(R0 − 1) which implies that Ed f is locally stable when R0 < 1 and unstable when R0 > 1.

For the eigenvalues of the Jacobian evaluated at E* it is true that λ1+λ2=(μ+d)(1R0μμ+d)<0 and λ1 × λ2 = (μ + d)[β(R0 − 1)2 + μR0(R0 − 1)] > 0 which implies that E* is locally stable when exists.

Finally by the Poincaré-Bendixson theorem we have the following results:

  • – when R0 < 1, Ed f is globally stable and E* does not exist;

  • – when R0 > 1, E* is globally stable and Ed f is unstable.

A.2 Proof of Proposition 2

The positivity of the solutions of Model (1) with proportional recruitment fP(N) can be easily proved. The equation for the total population size dNdt=dSdt+dIdt=rNμS(μ+d)I=(rμ)NdI(rμ)N implies that N(t) → 0 extinction if r < μ. It is clear that the extinction occurs even in the absence of HIV (I = 0) when the first equation of Model (1) becomes dSdt=(rμ)S. Next we study the case when r > μ.

We analyze the following fractional form of Model (1) with proportional recruitment fP(N):

dSdt=[r(βd)s](1s)dNdt=[rμd(1s)]Ni=1s.

Notice that the first equation is independent of N which allow us to study s(t) directly in the biologically feasible region {0 ≤ s ≤ 1}. Since s(0) ∈ (0, 1), then limts(t)=1 (and limti(t)=0) if:

  • β < d or

  • β > d and rβd1.

Combined, these two cases imply that if β < r + d then each solution of the fractional model approaches disease-free equilibrium. Under this condition the population size grows unbounded. Alternatively, if β > r + d all solutions of the fractional model approach the endemic equilibrium with limts(t)=rβd and limti(t)=1rβd. The equation for the population size N(t) implies that in this case the population extinction under HIV pressure will be caused if (μ + dr)β > (μ + d)d. Therefore the population is endangered only if r < μ + d and β<(μ+d)dμ+dr.

A.3 Proof of Proposition 3

The region {S ≥ 0, I ≥ 0, S + IK} is positive invariant under the model (1) with logistic recruitment which can be checked by determining the sign of the derivatives on the boundary. Given S + I > K in {S ≥ 0, I ≥ 0}, we have dNdt=rN(1NK)μNdIμN and thus the total population will decrease below carrying capicity. Therefore we consider only the region {S ≥ 0, I ≥ 0, S + IK}.

Periodic solutions in the region {S ≥ 0, I ≥ 0, S + IK} can be excluded by Dulac's Criteria. Let P(S,I)dSdt and Q(S,I)dIdt, then S(PSI)+I(QSI)=rK(1S+1I)rS2(1S+IK)<0.

The model has three possible steady states:

  1. Extinction equilibrium Eext = (0, 0) which always exist;

  2. Disease-free equilibrium Edf=(rμrK,0) which exists for r > μ and

  3. Endemic equilibrium E=rμd(11R0)rK(1R0,R01R0), where R0=βμ+d. It exist if R0 > 1 ⇔ β > μ + d and r>μ+d(11R0). The later is equivalent to β(μ + dr) < (μ + d)d which is true if:
    • r > μ + d or
    • r < μ + d and β<(μ+d)dμ+dr

Similar to Proposition 2, we can show that if r < μ then the population go extinct (N(t) → 0) and all solutions approach the extinction equilibrium Eext. Next we assume that r > μ.

Eigenvalues of the Jacobian matrix at Ed f are −(rμ) < 0 and β − (μ + d). It implies that when exists Ed f is stable when R0 < 1 ⇔ β < μ + d, and unstable otherwise.

Eigenvalues of the Jacobian matrix at E* satisfy λ1+λ2=[rμd(11R0)](11R0)(βd)<0 and λ1λ2=[rμd(11R0)][β(μ+d)]>0. It implies that E* is stable when exists.

The proof will be completed when the local stability of the extinction equilibrium Eext is analyzed. We follow an approach similar to one often used in the analysis of ratio-dependent population models (Hews et al. 2010). To avoid singularity at (0, 0) it is studied through the modified model in terms of the fraction of susceptibles s=SN and total population size N (note that infected fraction satisfies i=IN=1S):

dSdt=[r(1NK)+(dβ)s](1s)dNdt=[r(1NK)μd(1s)]N. (3)

It possesses two steady states E1 = (1, 0), E2=(rβd,0) corresponding to Eext.

The Jacobian matrix at E1 has an eigenvalue rμ > 0 which implies that E1 is unstable. Eigenvalues of the Jacobian matrix at E2 are λ1 = d + rβ and λ2=μ+dβd(βdR0r). It implies that E2 is stable if β > d + r and β > d + R0r. As a result Eext is stable if β > max{d + r, d + R0r} and unstable otherwise. Then,

  • – when R0 < 1 (β < μ + d), Eext is unstable since β < d + r. In this case endemic (E*) equilibrium does not exist while the disease-free (Ed f) steady state is stable;

  • – when R0 > 1 (β > μ + d), E00 is stable if β > d + R0r, i.e., when endemic (E*) equilibrium does not exist. In this case the disease-free (Ed f) steady state is unstable;

Finally the global stability results in the Proposition follow by Poincaré-Bendixson theorem.

A.4 Proof of Proposition 4

Positivity and boundedness of solutions can be easily proved. Then dSpdtkΛμSp implies limsuptSpkΛμ and dSdt(1k)ΛμS implies limsuptS(1k)Λμ. Therefore dNdt=dSpdt+dSdt+dIdt=ΛμNdIΛ(μ+d)N implies liminftNΛμ+d. Then in the long term we have SN(1k)(μ+d)μ, and SpNk(μ+d)μ, which implies dIdtI[β(1k)(μ+d)μ+(1αs)βk(μ+d)μ(μ+d)]=I(μ+d)2μ[β1kμ+d+(1αs)βkμ+dμμ+d]=I(μ+d)2μ(R0μμ+d). Now if R0<μμ+d, then because of the positivity of the solution, we know limtI=0. Then combining this result with the equations in Model (2), implies that limtSp=kΛμ and limtS=(1k)Λμ. Thus, global stability of the infection-free steady state Edf=(kΛμ,(1k)Λμ,0) under condition R0<μμ+d is proved. For local stability of E0, we consider the corresponding eigenvalues λ1 = −μ < 0, λ2 = −μ < 0 and λ3 = (μ + d)(R0 − 1). Therefore, Ed f is stable when R0 < 1 and unstable when R0 > 1.

Now we consider E*. By setting F(I) = 0 and dividing by Λ2 (μ + d), we obtain that I* is a root of:

F^(I)(R01)+((d(1αs)β)(μ+d(1αs)β)βμ+dd(R01))IΛ(dβ)(d(1αs)β)I2Λ2

Substituting in iN where iIN, and N=Λμ+di into (I) = 0 we notice that I* is also a root of:

F¯(iN)μ(μ+d)(1R0)+β(μ+dαsk(βμd)(1αs))i+(1αs)β2i2

Now substituting back in for I and N=ΛdIμ, we notice that I* is a root of:

F¯(I)=μ(μ+d)(1R0)+β(μ+dαsk(βμd)(1αs))IN+(1αs)β2I2N2

Now we have (0) = (R0 − 1) and F^(Λd)=(1αs)β2μd2(μ+d)<0.

Assume R0 > 1, then (0) > 0 and also β > d. Since (0) > 0, F^(Λd)<0 and is a second order polynomial, we have existence of a unique endemic equilibrium.

Assume R0 < 1. Since

μ+dαsk(βμd)(1αs)μ+dαskαsk(μ+d)(1αs1αsk)αsk(μ+d)(11αs1αsk)>0,

we have that (I) > 0 for all I(0,Λd) and therefore we have no solution I*.

Therefore when R0 < 1, there is only the disease-free equilibrium, Ed f, and whenever R0 > 1 there is both the disease-free equilibrium, Ed f, and the endemic equilibrium, E*.

Now we analyze the stability of the endemic equilibrium, E*. Because of the complexity of the expressions, we will not express the positive steady state explicitly. Now assume that R0=(1αsk)βμ+d>1.

The Jacobian of the system is:

J=((I+S)(1αs)N2βIμ(1αs)N2βSpI(Sp+S)(1αs)N2βSp1N2βSISp+IN2βIμSp+SN2βSI(I+S)αsN2βII+SpαsN2βI(Sp+S)(S+Sp(1αs))N2β(μ+d)).

Using

P=(111010001),

we see that the Jacobian is similar to

H=P1JP=(μ0d1N2βSI1NβIμ1NβSI(I+S)αsN2βIαsNβI(SpI)(1αs)+SNβ(μ+d)).

Rewriting H evaluated at the endemic equilibrium using pSPN, sSN, iIN, N=Λμ+di and i* + p* + s* = 1, we obtain:

H=(μ0dβsiβiμβs((s+i)(1αs)s)βiαsβi(1αs)βi)

where s=1αsβ(μ+d(1i)(1αs)β).

We have the characteristic polynomial:

f(λ)=λ3+Aλ2+Bλ+C

Where

A=(2αs)βi+2μ,B=(1αs)(βi+di+2μ)βi+μ(βi+μ)+αs(βd)βsiC=((1αs)(dβi2+dμi+μ(βi+μ))+αsμ(βd)s)βi.

Clearly if R0 > 1, then β > d, which implies that A > 0, B > 0 and C > 0. Also we have that

ABC=3μ2βi+2μ3+αs2μβ2i2+αsμ(βd)βis+αs(2αs)(βd)β2i2s+(1αs)(μdi+β2i2+6μβi+4μ2)βi+(1αs)2(μ+(β+d)i)β2i2>0.

Therefore by the Routh-Hurwitz Criteria, the endemic equilibria, E* is locally stable.

A.5 Proof of Proposition 5

We analyze the fractional model associated with proportional recruitment:

dpdt=krrp[(1αs)βd]piX(p,i) (4)
didt=[β(d+r)αsβp(βd)i]iY(p,i) (5)
s=1pi (6)
dNdt=[rμdi]N. (7)

Notice that the first two equations of the system (4) - (7) are decoupled from the rest which allow us to study the reduced system (4) and (5).

Positivity of solutions for the fractional system can be easily checked. Further,

dpdt+didt=krrpβpi+αspi+dpi+(βd)iriαsβpi(βd)i2=krr(p+i)βpi(βd)pi+(βd)i(βd)i2=krr(p+i)βpi+(βd)i[1(p+i)].

Then at p + i = 1, d(p+i)dt=r+krβpi=r(1k)βpi<0 implies that (p + i)(t) ≤ 1 for t > 0 given that (p + i)(0) ≤ 1.

The periodic solutions for the reduced system, and therefore for the transformed system, can be excluded by Dulac's Criteria: p(Xpi)+i(Ypi)=krp2iβdp<0, when given βd > 0.

For the reduced system, there are possibly several steady states: E1 = (k, 0) (always exists) and E2=(plin,ilin)(p,i) (positive steady state, existence depends on parameter values).

For E1, we have eigenvalues λ1 = −r < 0 and λ2 = (1 − αsk)β − (d + r). Therefore if (1 − αsk)β < (d + r), then E1 is locally stable; if (1 − αsk)β > (d + r), then E1 is unstable.

For E2, we have Ap*2 + Bp* + C = 0 and i=1αsβp+rβd, with A = αsβ[(1 − αs)βd], B = −{(βdr)[(1 − αs)βd] + (βd)r}, and C = (βd)kr. If further 0 < p* < 1 and 0 < i* < 1, then (p*, i*) exists as a positive steady state.

Notice that p(0,β(d+r)αsβ) and i(0,β(d+r)βd). So we assume that β > d + r. Denote F(p) = Ap2 + Bp + C, then we have the following results for F(p) over (0,β(d+r)αsβ):F(0)=(βd)kr>0, and F(β(d+r)αsβ)=(βd)rαsβ[(1kαs)β(d+r)]. Now if (1 − s)β > d + r, then F(0) > 0 and F(β(d+r)αsβ)<0 implies a unique solution of F (p) = 0 over ( 0,β(d+r)αsβ), because F(p) is a parabolic function.

Now consider the case when (1 − s)β < d + r (⇒ (1 − αs)βd < r). If (1 − αs)βd, then F(0) > 0 and F(β(d+r)αsβ)>0 implies no solution of F(p) = 0 over (0,β(d+r)αsβ), because F(p) is linear or concave down. If (1 − αs)β > d, then F(p) is concave up and attains its minimum at p^=β(d+r)2αsβ+(βd)r2αsβ[(1αs)βd]>β(d+r)2αsβ+(βd)r2αsβr>β(d+r)αsβ. Therefore if (1 − αs)β > d, then F(0) > 0 and F(β(d+r)αsβ)>0 implies no solution of F(p) = over ( 0,β(d+r)αsβ), because F(p) is decreasing over ( 0,β(d+r)αsβ).

Therefore if βd + r, we have a unique solution of F(p) = 0 over ( 0,β(d+r)αsβ) when (1 − s)β > d + r and no solution over ( 0,β(d+r)αsβ) when (1 − s)β < d + r.

Next, we can show that E2 is stable when it exists. Notice that the existence of E2 requires (1 − αsk)β > (d + r), when E1 is unstable. Also, we have

krrp[(1αs)βd]pi=0r[(1αs)βd]i=krp;[(1αs)βd]p=krrpi,

and

β(d+r)αsβp(βd)i=0.

And we have the following Jacobian matrix for E2:

J(E2)=|r[(1αs)βd]i[(1αs)βd]pαsβi(βd)i+β(d+r)αsβp(βd)i|.

Then

J(E2)=|krpkrrpiαsβi(βd)i|.

The corresponding eigenvalues satisfy

λ1+λ2=krp(βd)i<0,

and

λ1λ2=krp(βd)iαsβ(krrp).

Furthermore,

λ1λ2=krp(βd)(1αsβp+rβd)αsβ(krrp)=rp[k(βdαsβpr)αsβ(kp)p]=rp[αsβp22αsβkp+k(βdr)].

Therefore, λ1 · λ2 > 0 since f(p*) = αsβp*2 − 2αsβkp* + k(βdr) > 0. We know that f(p*) attains the minimum value f(k) at p* = k. Now it is sufficient to show that f(k) > 0. Since (1 − αsk)β > (d + r) ⇒ βdr > αs, then

f(k)=αsβk22αsβk2+k(βdr)=k(βdr)αsβk2>kαskβαsβk2=0.

Thus, we have proven that E2 is stable when it exists, i.e., require (1 − αsk)β > (d + r). Further since (1 − αsk)β > (d + r) implies β > d (no periodic solutions) and E1 is unstable, then E2 is globally stable when it exists.

If (1 − αsk)β < (d + r), then E1 is stable and E2 does not exist. Further β > d implies no periodic solutions, therefore we conclude that E1 is globally stable provided that (1 − αsk)β < (d + r) and β > d.

Now, for the original system, similar to Proposition 2, we can show that the unique steady state E = (0, 0, 0) is globally stable if r < μ. Next we will study the cases when r > μ. We know that when β > d, E1 = (k, 0) is globally stable when (1 − k)β + k(1 − αs)β < d + r, while E2 = (p*, i*) is globally stable when (1 − k)β + k(1 − αs)β > d + r. Then by (6), the total population N(t) either approaches 0 when rμdlimti(t)<0, or blows up when rμdlimti(t)>0. Similarly by (7), the infected population I(t) either approaches 0 when β(1limtp(t)limti(t))+(1αs)βlimtp(t)(μ+d)<0, or blows up when β(1limtp(t)limti(t))+(1αs)βlimtp(t)(μ+d)>0. Thus, periodic solutions for (2) do not exist when β > d.

Further, if r > μ + d, then rμdlimti(t)>0 and the population grows unbounded. Now assume that μ < r < μ + d. Substituting in i=1αsβp+rβd and p* into the above we derive conditions for population extinction. We obtain

β(1pi)+(1αs)βp(μ+d)=0

which yields p=(μ+d)(βd)rβdαsβ. Then substituting the expression for p* into the equation Ap*2 + Bp* + C = 0 and dividing out βd gives us the following conditions for population extinction: if β > β̄ there is population extinction and if β < β̄ the population grows unbounded, where β̄ is a solution to the equation:

aβ2+bβ+c=0 (8)

with

a=(rμ)(1αs)(rμd)b=d((rμ)(μ+d)(1αs)+(rμ)μ+d(rαskμ))c=μd2(μ+d).

Whenever μ < r < μ + d, we see that a < 0 and c > 0. Therefore by Descartes' rule of signs, there is exactly one positive solution, namely, β¯=b¯b¯24ac¯2a¯. Moreover we have β¯>r+d1αsk.

A.6 Proof of Proposition 6

The invariance of the biologically feasible region can be easily proved. Given Sp + S + I > K in {Sp ≥ 0, S ≥ 0, I ≥ 0}, we have dNdt=rN(1NK)μNdIμN and thus the total population will decrease below carrying capicity. Therefore we consider only the region {Sp ≥ 0, S ≥ 0, I ≥ 0, Sp + S + IK}. Then similar to Proposition 2, we can show that the extinction steady state Eext is globally stable if r < μ.

We analyze the fractional model associated with logistic recruitment:

dpdt=kr(1NK)r(1NK)p((1αs)βd)pididt=((βd)(1i)r(1NK)αsβp)idNdt=(r(1NK)μdi)N. (9)

From now on, we assume r > μ. For the eigenvalues for Ed f, we have λ1 + λ2 = −r < 0, λ1 · λ2 = μ(rμ) > 0 and λ3 = (μ + d)(R0 − 1). Therefore Ed f is stable when R0 < 1 and unstable when R0 > 1.

Next, we prove that when μ < r < μ + d, the extinction steady state is stable if β > β̄ and unstable if β < β̄, where β̄ is a solution of Equation (8); and that the positive steady state also exists if β < β̄. Furthermore when r > μ + d, we prove that the positive steady state exists if R0 > 1.

For Model (9), there are possibly several steady states: E1 = (k, 0, 0) (always exists), E2 = (p*, i*, 0) (existence depends on parameter values), E3=(k,0,rμrK), and E4=(plog,ilog,N) (existence depends on parameter values). Notice that E3 is equivalent with Edf=(krμμK,(1k)rμμK,0) for (2), and E4 is equivalent with the positive steady state E* for (2) when it exists, while E1 and E2 are both corresponding to Eext = (0, 0, 0) for Model (2). Let us assume that r > μ.

For E1, we have eigenvalues λ1 = −r < 0, λ2 = (1 − αsk)β − (d + r), and λ3 = rμ > 0. So E1 is unstable.

For E2, we have Ap*2 + Bp* + C = 0 and i=1αsβp+rβd, with A = αsβ[(1 − αs)βd], B = −{(βdr)[(1 − αs)βd] + (βd)r}, and C = (β − d)kr. If further 0 ≤ p* ≤ 1 and 0 ≤ i* ≤ 1, then (p*, i*, 0) exists as a steady state. This is similar to the case E2 = (p*, i*) in Proposition 5 (with proportional recruitment) when taking N* = 0. We obtain that E2 is stable whenever μ < r < μ + d and β > β̄ and unstable otherwise.

For E4=(plog,ilog,N)(p,i,N), we have Ap*2 + Bp* + C = 0, i=βμdαsβpβ, N=rμdirK, with A = αs(1 − αs)β, B = −[(1 − αs)(βμd) + μ + sd], and C=kdβμdβ+kμ. Therefore, positive steady states may exist but are too complicated to be expressed explicitly.

Notice that i(0,rμd) and p(β(μ+d)rμdαsβ,β(μ+d)αsβ). So we assume that β > μ + d and r > μ so that E4 may exist as an endemic steady state. Denote F(p) = Ap2 + Bp + C, then we have the following results for F(p) over( 0,β(μ+d)αsβ): Since A > 0, B < 0, and C > 0, we have

0<BΔ2A<B+Δ2A

where

Δ=B24AC. (10)

Since F(0)=k(μ+d)(βd)β>0 and F(β(μ+d)αsβ)=μ(μ+d)αsβ(R01)<0, then there is only one solution on the interval (0,β(μ+d)αsβ), and we have that when it exists, p=BΔ2A.

Also we have that p* is a solution on the interval if and only if F(β(μ+d)βrμdαsβ)>0. That is:

(1αs)β2(rμ)2+d3μdβ(rμ)(βμ)(1αs)+dβμ(rμ)d2αsβ+d2(r(1(1k)αs)β+μ(μβ(2αs)))d2αsβ>0.

Given R0 > 1 and r > μ, we have β>μ+d1αsk. This provides the following conditions for existence:

  • r > μ + d

  • r < μ + d and β(μ+d)dμ+dr

  • (μ+d)μμ+dkr<μ+d and β¯>β>(μ+d)dμ+dr

  • r<(μ+d)μμ+dk and β¯>β>(μ+d)dμ+dr

where β̄ is a solution to the equation (8). The above conditions reduce to:

  • r > μ + d and β>μ+d1αsk

  • μ < r < μ + d and β¯>β>μ+d1αsk.

Now consider the case when R0<1(β<μ+d1kαs). F(p) is concave up and attains its minimum at p^=β(μ+d)2αsβ+μ+kαsd2αs(1αs)β>β(μ+d)αsβ, since

β(μ+d)2αsβ+μ+kαsd2αs(1αs)ββ(μ+d)αsβ=μ+kαsd(1αs)[β(μ+d)]2αs(1αs)β>μ+kαsd(1αs)[μ+d1kαs(μ+d)]2αs(1αs)β=(2αs1αs1kαs)μ+kαs(11αs1kαs)d2αs(1αs)β>0.

Therefore F(β(μ+d)αsβ)>0 implies no solution of F(p) = 0 over (β(μ+d)rμdαsβ,β(μ+d)αsβ), because F(p) is decreasing over (β(μ+d)rμdαsβ,β(μ+d)αsβ).

Thus when R0 > 1, if either r > μ + d or both β < β̄ and μ < r < μ + d, we have a unique solution of F(p) = 0 over (β(μ+d)rμdαsβ,β(μ+d)αsβ). Also there is no solution over (β(μ+d)rμdαsβ,β(μ+d)αsβ) whenever either R0 < 1 or if R0 > 1 we have both μ < r < μ + d and β > β̄.

Now we give partial results for the stability of E4. The Jacobian evaluated at E4 can be expressed as:

J=(μ(1αs)βi((1αs)βd)prK(k+p)αsβi(βd)irKi0dNrKN)

which has characteristic polynomial

f(λ)=λ3+Aλ2+Bλ+C

where

A=(βd)i+(1α)βi+NrK+μ,B=i(βd)(iβ(1αs)+μ)+ipαsβ(dβ(1αs))+NrK(iβ+iβ(1αs)+μ),

and

C=NriβK(dkαs+μ+(ipαs)β(1αs)).

Given R0 > 1 and i<rμd, we have A > 0. Substituting in for i* and p* we obtain:

C=NriβKΔ>0,

where Δ is as in (10). Therefore the equilibium is locally stable if and only if ABC > 0. We have the following

ABC=(i(1αs)β+i(βd)+NrK+μ)(id(β(pαsi(1αs))βkαsμ))+Nr(iβ+i(1αs)β+μ)K(i(1αs)β+i(βd)+NrK+μ)+iβΔ(i(1αs)β+I(βd)+μ).

Due to the complexity of the above expression, we have only numerically verified for plausible parameter values, that the equilibrium, E4, is locally stable whenever it exists.

Now we show that the HIV prevalence associated with Model (2) under logistic and constant recruitment is the same, i.e., iconst=ilog, whenever both equilibria exist and are stable. Assume R0=(1αsk)βμ+d>1. We have shown already that with constant recruitment, the infected population, I*, is a root of:

F^(I)AI2+BI+C

Where

A=(dβ)(d(1αs)β)1Λ2,B=((d(1αs)β)(1βμ+d)μβμ+dd(R01))1Λ,C=R01.

Next, we calculate I*. R0 > 1 implies that β>μ+d1αsk>μ+d>d. Thus we have

d(1αs)β<d(1αs)(μ+d)1αsk<d(μ+d)=μ

and therefore, A < 0 and C > 0. By Descartes' rule of signs there is exactly one positive root of (I). Since I* > 0, we must have that

I=BB24AC2A.

The total population is given by N=ΛdIμ, so that

N=ΛdIμ.

Therefore, the HIV prevalence under constant recruitment is

iconst=IN=μIΛdI.

First, notice that Λ factors out of I* and thus will be absent in the final expression. Substituting in for I*, we have that after rationalizing the denominator

iconst=(1αs)(βμd)μαskd+Δconst2(1αs)β,

Where

Δconst=Λ2(μ+d)2β2(β24AC).

We already have shown that the HIV prevalence given logistic growth is

ilog=1αspμ+dβ,

Where

p=B¯Δlog2Λ,Δlog=B¯24A¯C¯,

and

A¯=αs(1αs)β,B¯=((1αs)(βμd)+μ+kαsd),C¯=kdβμdβ+kμ.

Substituting p* into ilog and simplifying, we obtain

ilog=(1αs)(βμd)μαskd+Δlog2(1αs)β.

It can be checked that Δconst = Δlog, and therefore iconst=ilog.

B Demographic data and simulations for the Republic of South Africa

Age structured population data about the Republic of South Africa for year 2001 and from year 2003 to 2011, in thousands, is presented in Table 5. The data has been adapted from Statistics South Africa (Africa 2012). In the table, T(15-49) refers to total population of individuals from age 15 to 49. Similarly, P(15-49) refers to HIV prevalence among people of age 15 to 49. HIV-T and SUS-T refer to total number of infected and susceptible individuals ages 15 to 49, respectively.

Table 5.

Age structured population for the Republic of South Africa.

Age\Year 2001 2003 2004 2005 2006 2007 2008 2009 2010 2011
15-19 4982 5263 4924 4898 4938 4976 5153 5214 5226 5175
20-24 4295 4392 4679 4621 4654 4675 4784 4921 5019 4900
25-29 3935 4100 4292 4211 4271 4336 4367 4424 4519 4598
30-34 3341 3422 3696 3762 3842 3864 3914 3888 4036 4041
35-39 3072 3217 2851 2780 2842 2972 3147 3282 3465 3600
40-44 2619 2794 2537 2483 2428 2400 2390 2443 2524 2613
45-49 2087 2242 2214 2187 2215 2222 2241 2260 2231 2245
T(15-49) 24331 25431 25195 24943 25190 25446 25995 26433 27019 27172
P(15-49) 0.16 0.162 0.162 0.162 0.166 0.165 0.164 0.164 0.165 0.166
HIV-T 3893 4120 4082 4041 4181 41994 4263 4335 4458 4511
SUS-T 20438 21311 21114 20902 21008 21247 21732 22098 22561 22662

Parameter values generated from data fitting are listed in Table 6 and the corresponding simulations using fitted parameter values are presented in Figs. 5 and 6.

Table 6.

Parameter values generated from data fitting.

Parameter Recruitment mechanism
constant proportional logistic
β 0.196924711 0.196935536 0.196924711
μ 0.029793556 2.93E-02 0.02438153
d 0.119146121 0.11955454 0.125
Λ 996344
r 0.04095 0.0511875
K 1.13E+08

err 0.044056109 0.044755966 0.043080597

Fig. 5.

Fig. 5

Population dynamics for models with different recruitment rates: constant (blue –), proportional (red Inline graphic), and logistic (black --). Initial recruitment and parameter values unrelated to recruitment are generated from data fitting (see Table 6).

Fig. 6.

Fig. 6

PrEP effectiveness over 200 years for models with different recruitment rates: constant (blue –), proportional (red Inline graphic), and logistic (black --). Initial recruitment and parameter values unrelated to recruitment are generated from data fitting (see Table 6).

Contributor Information

Yuqin Zhao, School of Mathematics, University of Minnesota, Minneapolis, MN.

Daniel T. Wood, Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, Tel.: +1-206-667-1933, Fax: +1-206-667-4812.

Hristo V. Kojouharov, Department of Mathematics, The University of Texas at Arlington, Arlington, TX, USA

Yang Kuang, Department of Mathematics and Statistics, Arizona State University, Tempe, AZ.

Dobromir T. Dimitrov, Email: ddimitro@scharp.org, Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, Tel.: +1-206-667-1933, Fax: +1-206-667-4812.

References

  1. Abbas UL, Glaubius R, Mubayi A, Hood G, Mellors JW. Antiretroviral therapy and pre-exposure prophylaxis: Combined impact on HIV transmission and drug resistance in South Africa. Journal of Infectious Diseases. 2013;208(2):224–234. doi: 10.1093/infdis/jit150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abbas Ume L, Anderson Roy M, Mellors John W. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One. 2007;2(9):e875. doi: 10.1371/journal.pone.0000875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Statistics South Africa. Mid-year population estimates, 2011. Stats SA: Statistical release P0302. 2012 [Google Scholar]
  4. Auvert Bertran, Taljaard Dirk, Lagarde Emmanuel, Sobngwi-Tambekou Joelle, Sitta Rémi, Puren Adrian. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Medicine. 2005;2(11):e298. doi: 10.1371/journal.pmed.0020298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bacaer N, Pretorius C, Auvert B. An age-structured model for the potential impact of generalized access to antiretrovirals on the South African HIV epidemic. Bulletin of Mathematical Biology. 2010;72(8):2180–2198. doi: 10.1007/s11538-010-9535-2. [DOI] [PubMed] [Google Scholar]
  6. Baeten Jared M, Donnell Deborah, Ndase Patrick, Mugo Nelly R, Campbell James D, Wangisi Jonathan, Tappero Jordan W, Bukusi Elizabeth A, Cohen Craig R, Katabira Elly, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine. 2012;367(5):399–410. doi: 10.1056/NEJMoa1108524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bailey Robert C, Moses Stephen, Parker Corette B, Agot Kawango, Maclean Ian, Krieger John N, Williams Carolyn FM, Campbell Richard T, Ndinya-Achola Jeckoniah O. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet. 2007;369(9562):643–656. doi: 10.1016/S0140-6736(07)60312-2. [DOI] [PubMed] [Google Scholar]
  8. Becquet Renaud, Ekouevi Didier K, Arrive Elise, Stringer Jeffrey SA, Meda Nicolas, Chaix Marie-Laure, Treluyer Jean-Marc, Leroy Valériane, Rouzioux Christine, Blanche Stéphane, et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clinical Infectious Diseases. 2009;49(12):1936–1945. doi: 10.1086/648446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Berezovsky F, Karev G, Song B, Castillo-Chavez C. A simple epidemic model with surprising dynamics. Mathematical Biosciences and Engineering. 2005;2(1):133–152. doi: 10.3934/mbe.2005.2.133. [DOI] [PubMed] [Google Scholar]
  10. Boily Marie-Claude, Bastos Francisco I, Desai Kamal, Masse Benoit. Changes in the transmission dynamics of the hiv epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: Results from mathematical models sexually transmitted diseases. Sexually Transmitted Diseases. 2004;31(2):100–112. doi: 10.1097/01.OLQ.0000112721.21285.A2. [DOI] [PubMed] [Google Scholar]
  11. Boily Marie-Claude, Baggaley Rebecca F, Wang Lei, Masse Benoit, White Richard G, Hayes Richard J, Alary Michel. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. The Lancet Infectious Diseases. 2009;9(2):118–129. doi: 10.1016/S1473-3099(09)70021-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Kitisin P, Natrujirote P, Kittimunkong S, Chuachoowong R, Gvetadze RJ, McNicholl JM, Paxton LA, Curlin ME, Hendrix CW, Vanichseni S. Antiretroviral prophylaxis for hiv infection in injecting drug users in bangkok, thailand (the bangkok tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013;381(9883):2083–2090. doi: 10.1016/S0140-6736(13)61127-7. [DOI] [PubMed] [Google Scholar]
  13. Cohen Myron S, Chen Ying Q, McCauley Marybeth, Gamble Theresa, Hosseinipour Mina C, Kumarasamy Nagalingeswaran, Hakim James G, Kumwenda Johnstone, Grinsztejn Beatriz, Pilotto Jose HS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine. 2011;365(6):493–505. doi: 10.1056/NEJMoa1105243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cox Andrew P, Foss Anna M, Shafer Leigh Anne, Nsubuga Rebecca N, Vickerman Peter, Hayes Richard J, Watts Charlotte, White Richard G. Attaining realistic and substantial reductions in hiv incidence: model projections of combining microbicide and male circumcision interventions in rural uganda. Sexually Transmitted Infections. 2011;87(7):635–639. doi: 10.1136/sti.2010.046227. [DOI] [PubMed] [Google Scholar]
  15. Cremin Ide, Alsallaq Ramzi, Dybul Mark, Piot Peter, Garnett Geoffrey, Hallett Timothy B. The new role of antiretrovirals in combination hiv prevention: a mathematical modelling analysis. AIDS. 2013;27(3):447–458. doi: 10.1097/QAD.0b013e32835ca2dd. [DOI] [PubMed] [Google Scholar]
  16. Desai Kamal, Sansom Stephanie L, Ackers Marta L, Stewart Scott R, Hall H Irene, Hu Dale J, Sanders Rachel, Scotton Carol R, Soorapanth Sada, Boily Marie-Claude, Garnett Geoffrey P, McElroy Peter D. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS. 2008;22(14):1829–1839. doi: 10.1097/QAD.0b013e32830e00f5. [DOI] [PubMed] [Google Scholar]
  17. Dimitrov D, Boily MC, Mâsse BR, Brown ER. Impact of pill sharing on drug resistance due to a wide-scale oral prep intervention in generalized epidemics. Journal of AIDS & Clinical Research. 2012;5:2. doi: 10.4172/2155-6113.s5-004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dimitrov DT, Masse B, Boily MC. Who will benefit from a wide-scale introduction of vaginal microbicides in developing countries? Statistical Communications in Infectious Diseases. 2010;2 doi: 10.2202/1948-4690.1012. Article 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dimitrov DT, Boily MC, Baggaley RF, Masse B. Modeling the gender-specific impact of vaginal microbicides on hiv transmission. Journal Of Theoretical Biology. 2011;288:9–20. doi: 10.1016/j.jtbi.2011.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dimitrov DT, Kuang Y, Masse BR. Assessing the impact of hiv interventions on public health: mathematic models must account for changing demographics. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2014;66(2):e60–e62. doi: 10.1097/QAI.0b013e3182785638. 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dimitrov Dobromir, Boily Marie-Claude, Brown Elizabeth R, Hallett Timothy B. Analytic review of modeling studies of arv based prep interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness. PLoS ONE. 2013a;8(11):e80927. doi: 10.1371/journal.pone.0080927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dimitrov Dobromir T, Mâsse Benoît R, Boily Marie-Claude. Beating the placebo in hiv prevention efficacy trials: the role of the minimal efficacy bound. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013b;62(1):95–101. doi: 10.1097/QAI.0b013e3182785638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Eaton Jeffrey W, Hallett Timothy B. Why the proportion of transmission during early-stage hiv infection does not predict the long-term impact of treatment on hiv incidence. Proceedings of the National Academy of Sciences. 2014;111(45):16202–16207. doi: 10.1073/pnas.1323007111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Granich Reuben M, Gilks Charles F, Dye Christopher, De Cock Kevin M, Williams Brian G. Universal voluntary hiv testing with immediate antiretroviral therapy as a strategy for elimination of hiv transmission: a mathematical model. The Lancet. 2009;373(9657):48–57. doi: 10.1016/S0140-6736(08)61697-9. [DOI] [PubMed] [Google Scholar]
  25. Grant Robert M, Lama Javier R, Anderson Peter L, McMahan Vanessa, Liu Albert Y, Vargas Lorena, Goicochea Pedro, Casapía Martín, Guanira-Carranza Juan Vicente, Ramirez-Cardich Maria E, et al. Preexposure chemoprophylaxis for hiv prevention in men who have sex with men. New England Journal of Medicine. 2010;363(27):2587–2599. doi: 10.1056/NEJMoa1011205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gray Ronald H, Kigozi Godfrey, Serwadda David, Makumbi Frederick, Watya Stephen, Nalugoda Fred, Kiwanuka Noah, Moulton Lawrence H, Chaudhary Mohammad A, Chen Michael Z, et al. Male circumcision for hiv prevention in men in rakai, uganda: a randomised trial. The Lancet. 2007;369(9562):657–666. doi: 10.1016/S0140-6736(07)60313-4. [DOI] [PubMed] [Google Scholar]
  27. Hews S, Eikenberry S, Nagy JD, Kuang Y. Rich dynamics of a Hepatitis B viral infection model with logistic hepatocyte growth. J Math Biol. 2010;60:573–590. doi: 10.1007/s00285-009-0278-3. [DOI] [PubMed] [Google Scholar]
  28. Hwang TW, Kuang Y. Deterministic extinction effect of parasites on host populations. Journal of Mathematical Biology. 2003;46(1):17–30. doi: 10.1007/s00285-002-0165-7. [DOI] [PubMed] [Google Scholar]
  29. Juusola Jessie L, Brandeau Margaret L, Owens Douglas K, Bendavid Eran. The cost-effectiveness of preexposure prophylaxis for hiv prevention in the united states in men who have sex with men. Annals of Internal Medicine. 2012;156(8):541–550. doi: 10.1059/0003-4819-156-8-201204170-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kalichman Seth C, Simbayi LC, Cain Demetria, Jooste Sean. Heterosexual anal intercourse among community and clinical settings in cape town, south africa. Sexually Transmitted Infections. 2009;85(6):411–415. doi: 10.1136/sti.2008.035287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Abdool Karim Quarraisha, Abdool Karim Salim S, Frohlich Janet A, Grobler Anneke C, Baxter Cheryl, Mansoor Leila E, Kharsany Ayesha BM, Sibeko Sengeziwe, Mlisana Koleka P, Omar Zaheen, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of hiv infection in women. Science. 2010;329(5996):1168–1174. doi: 10.1126/science.1193748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kato Masaya, Granich Reuben, Bui Duong D, Tran Hoang V, Nadol Patrick, Jacka David, Sabin Keith, Suthar Amitabh B, Mesquita Fabio, Lo Ying Ru, Williams Brian. The potential impact of expanding antiretroviral therapy and combination prevention in vietnam: Towards elimination of hiv transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013;63(5):e142–e149. doi: 10.1097/QAI.0b013e31829b535b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Korobeinikov Andrei. Lyapunov functions and global stability for sir and sirs epidemiological models with non-linear transmission. Bulletin of Mathematical Biology. 2006;68(3):615–626. doi: 10.1007/s11538-005-9037-9. [DOI] [PubMed] [Google Scholar]
  34. Morgan Dilys, Mahe Cedric, Mayanja Billy, Okongo J Martin, Lubega Rosemary, Whitworth James AG. Hiv-1 infection in rural africa: is there a difference in median time to aids and survival compared with that in industrialized countries? AIDS. 2002;16(4):597–603. doi: 10.1097/00002030-200203080-00011. [DOI] [PubMed] [Google Scholar]
  35. Nichols Brooke E, Boucher Charles AB, van Dijk Janneke H, Thuma Phil E, Nouwen Jan L, Baltussen Rob, van de Wijgert Janneke, Sloot Peter MA, van de Vijver David AMC. Cost-effectiveness of pre-exposure prophylaxis (prep) in preventing hiv-1 infections in rural zambia: A modeling study. PloS One. 2013;8(3):e59549. doi: 10.1371/journal.pone.0059549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Porter Kholoud, Zaba Basia. The empirical evidence for the impact of hiv on adult mortality in the developing world: data from serological studies. AIDS. 2004;18:S9–S17. doi: 10.1097/00002030-200406002-00002. [DOI] [PubMed] [Google Scholar]
  37. Sorensen Stephen W, Sansom Stephanie L, Brooks John T, Marks Gary, Begier Elizabeth M, Buchacz Kate, DiNenno Elizabeth A, Mermin Jonathan H, Kilmarx Peter H. A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PloS One. 2012;7(2):e29098. doi: 10.1371/journal.pone.0029098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Supervie Virginie, García-Lerma J Gerardo, Heneine Walid, Blower Sally. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proceedings of the National Academy of Sciences. 2010;107(27):12381–12386. doi: 10.1073/pnas.1006061107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Supervie Virginie, Barrett Meagan, Kahn James S, Musuka Godfrey, Moeti Themba Lebogang, Busang Lesogo, Blower Sally. Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance. Scientific Reports. 2011;1 doi: 10.1038/srep00185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, Brooks JT. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine. 2012;367(5):423–434. doi: 10.1056/NEJMoa1110711. [DOI] [PubMed] [Google Scholar]
  41. UNAIDS. AIDS epidemic update: December 2009. WHO Regional Office Europe; 2009. [Google Scholar]
  42. Vickerman Peter, Terris-Prestholt Fern, Delany Sinead, Kumaranayake Lilani, Rees Helen, Watts Charlotte. Are targeted HIV prevention activities cost-effective in high prevalence settings? results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sexually Transmitted Diseases. 2006;30(Suppl 10):S122–S132. doi: 10.1097/01.olq.0000221351.55097.36. [DOI] [PubMed] [Google Scholar]
  43. Wawer Maria J, Gray Ronald H, Sewankambo Nelson K, Serwadda David, Li Xianbin, Laeyendecker Oliver, Kiwanuka Noah, Kigozi Godfrey, Kiddugavu Mohammed, Lutalo Thomas, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Journal of Infectious Diseases. 2005;191(9):1403–1409. doi: 10.1086/429411. [DOI] [PubMed] [Google Scholar]
  44. Wilson David P, Coplan Paul M, Wainberg Mark A, Blower Sally M. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proceedings of the National Academy of Sciences. 2008;105(28):9835–9840. doi: 10.1073/pnas.0711813105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zhao Yuqin, Dimitrov Dobromir T, Liu Hao, Kuang Yang. Mathematical insights in evaluating state dependent effectiveness of HIV prevention interventions. Bulletin of Mathematical Biology. 2013:1–27. doi: 10.1007/s11538-013-9824-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES